Abiopharma

New Form SCHEDULE 13G/A - Abivax S.A. Filed: 2025-08-14 AccNo: 0001172661-25-003272 Size: 11 KB

New Form SCHEDULE 13G/A - Terns Pharmaceuticals, Inc. Filed: 2025-08-14 AccNo: 0001172661-25-003270 Size: 11 KB

New Form SCHEDULE 13G/A - Zura Bio Ltd Filed: 2025-08-14 AccNo: 0001172661-25-003269 Size: 12 KB

New Form 10-Q - Evofem Biosciences, Inc. Filed: 2025-08-14 AccNo: 0001641172-25-023741 Size: 10 MB

New Form SCHEDULE 13G/A - Regulus Therapeutics Inc. Filed: 2025-08-14 AccNo: 0001172661-25-003268 Size: 11 KB

New Form SCHEDULE 13G/A - PLIANT THERAPEUTICS, INC. Filed: 2025-08-14 AccNo: 0001172661-25-003267 Size: 11 KB

New Form 8-K - Evofem Biosciences, Inc. Filed: 2025-08-14 AccNo: 0001641172-25-023740 Size: 328 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - Korro Bio, Inc. Filed: 2025-08-14 AccNo: 0001172661-25-003263 Size: 11 KB

New Form SCHEDULE 13G/A - Structure Therapeutics Inc. Filed: 2025-08-14 AccNo: 0001172661-25-003262 Size: 11 KB

New Form SCHEDULE 13G/A - GERON CORP Filed: 2025-08-14 AccNo: 0001172661-25-003261 Size: 11 KB

New Form SCHEDULE 13G/A - BICYCLE THERAPEUTICS PLC Filed: 2025-08-14 AccNo: 0001172661-25-003260 Size: 11 KB

Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update

New Form SCHEDULE 13G/A - Allakos Inc. Filed: 2025-08-14 AccNo: 0001172661-25-003258 Size: 11 KB

New Form 6-K - Enlivex Therapeutics Ltd. Filed: 2025-08-14 AccNo: 0001213900-25-076091 Size: 34 KB

New Form 8-K - Clene Inc. Filed: 2025-08-14 AccNo: 0001437749-25-026690 Size: 717 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: …